Citalopram, an anti-depressant, and Finasteride, a drug used to treat benign prostatic hyperplasia, or enlargement of the prostate gland, have both been recalled by the company Greenstone LLC due to mislabelling. This is because a third party manufacturer has put the wrong labels on the medication. Some of the Citalopram has been labeled as Finasteride.
Lot number FI0510058-A is affected. The bottles contain 90 tablets.
Finasteride should not be taken by pregnant women because it could cause reproductive abnormalities in a male fetus. The development of the external genitalia may be adversely affected. Therefore, if you are pregnant or may become pregnant and you have taken the wrong medication, please see your doctor immediately.
Citalopram is not suitable for patients who take monoamine oxidase inhibitors (MAOIs) or the drug pimozide. It is also not suitable for patients who have hypersensitivity to citalopram or to any of other ingredients in citalopram.
If you have a bottle of the affected lot number it should be returned to your pharmacist.
If you have had an adverse event related to this product, you can report it to the U.S. Food and Drug Administration online at: